Bonhomme; Yves

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bonhomme; Yves.The latest application filed is for "butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes".

Company Profile

0.15.7

Bonhomme; Yves - Charbonnieres les Bains FR
Bonhomme; Yves - Charbonnieres FR
Bonhomme; Yves - Charbonniees les Bains FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes Grant 8,247,448 - Zeiller , et al. August 21, 2	2012-08-21
Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof Grant 8,063,067 - Zeiller , et al. November 22, 2	2011-11-22
Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia, atherosclerosis and diabetes Grant 7,820,847 - Zeiller , et al. October 26, 2	2010-10-26
Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes App 20100261789 - Zeiller; Jean-Jacques ; et al.	2010-10-14
Substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them Grant 7,737,176 - Brunet , et al. June 15, 2	2010-06-15
Use of Rev-erb family of receptors in screening Grant 7,691,628 - Raspe , et al. April 6, 2	2010-04-06
Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof Grant 7,678,831 - Zeiller , et al. March 16, 2	2010-03-16
Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof Grant 7,632,846 - Zeiller , et al. December 15, 2	2009-12-15
Hexenoic Acid Derivatives, Processes For The Preparation Thereof, Pharmaceutical Compositions Comprising Them, And Therapeutic Applications Thereof App 20090286776 - ZEILLER; Jean Jacques ; et al.	2009-11-19
Carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia Grant 7,482,484 - Adje , et al. January 27, 2	2009-01-27
Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof Grant 7,465,752 - Zeiller , et al. December 16, 2	2008-12-16
Hexenoic Acid Derivatives, Processes for the Preparation Thereof, Pharmaceutical Compositions Comprising Them, and Therapeutic Applications Thereof App 20080194564 - Zeiller; Jean Jacques ; et al.	2008-08-14
Butanoic Acid Derivatives, Processes For The Preparation Thereof, Pharmaceutical Compositions Comprising Them, And Therapeutic Applications Thereof App 20080032982 - Zeiller; Jean Jacques ; et al.	2008-02-07
Pentenoic Acid Derivatives, Processes For The Preparation Thereof, Pharmaceutical Compositions Comprising Them, And Therapeutic Applications Thereof App 20080015253 - Zeiller; Jean Jacques ; et al.	2008-01-17
Butenoic acid derivatives processes for the preparation thereof pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia atherosclerosis and diabetes App 20060178434 - Zeiller; Jean-Jacques ; et al.	2006-08-10
Novel substituted arylhexadienoic acids and esters thereof which can be used for thetreatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositios comprising them and processes for the preparation of them App 20060052447 - Brunet; Michel ; et al.	2006-03-09
Use of ROR for receptors for screening substances useful for the treatment of atherosclerosis Grant 6,998,254 - Raspe , et al. February 14, 2	2006-02-14
Solid oral dosage form comprising a combination of metformin and glibenclamide Grant RE38,629 - Bonhomme , et al. October 19, 2	2004-10-19
Combination for the treatment of alcohol and drug dependence containing an opioid antagonist and a NMDA receptor complex modulator Grant 6,512,009 - Daoust , et al. January 28, 2	2003-01-28
Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia Grant 6,372,790 - Bonhomme , et al. April 16, 2	2002-04-16
Solid oral dosage form comprising a combination of metformin and glibenclamide Grant 6,303,146 - Bonhomme , et al. October 16, 2	2001-10-16
Dosage form of hydroxocobalamin and its use in cyanide poisoning Grant 5,834,448 - Pouchol , et al. November 10, 1	1998-11-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.